ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMLN Amylin Pharmaceuticals, Inc. (MM)

30.98
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Amylin Pharmaceuticals, Inc. (MM) NASDAQ:AMLN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 30.98 0 01:00:00

Europe Situation Forecasts Change -- Report Highlights Amylin Pharmaceuticals, Inc. and priceline.com Incorporated

11/11/2011 2:00pm

Marketwired


Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Amylin Pharmaceuticals, Inc. (MM) Charts.

Today, www.BrightonMarkets.com announced new reports highlighting Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) and priceline.com Incorporated (NASDAQ: PCLN). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=AMLN&cob=PCLN.

With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% haircut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.

Brighton Markets is releasing new coverage on Amylin Pharmaceuticals, Inc. for its current position within the healthcare industry. Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Its wholly owned subsidiaries are Amylin Ohio, LLC, and Amylin Investments, LLC. The full research report on Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is available here: www.BrightonMarkets.com/index.php?coa=AMLN.

Brighton Markets has released research on priceline.com Incorporated for its changing role within the services industry. priceline.com Incorporated is a global online travel company that offers its customers a range of travel services, including the opportunity to purchase hotel room reservations, car rentals, airline tickets, vacation packages, cruises and destination services in a price-disclosed manner. The full research report on priceline.com Incorporated (NASDAQ: PCLN) is available here: www.BrightonMarkets.com/index.php?cob=PCLN.

About Brighton Markets Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact: Jean Barnes Email: Email Contact www.BrightonMarkets.com

1 Year Amylin Pharmaceuticals, Inc. (MM) Chart

1 Year Amylin Pharmaceuticals, Inc. (MM) Chart

1 Month Amylin Pharmaceuticals, Inc. (MM) Chart

1 Month Amylin Pharmaceuticals, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock